| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Multiple-breath inhalational induction | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Induction of general anesthesia | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Intravenous induction by target-controlled infusion | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Inhaled steroid therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 3 | 
| Administration of prophylactic coagulation factor Xa inhibitor | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic direct thrombin inhibitor | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Mesalamine therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Levothyroxine therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Stimulant therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Alcohol-oxygen vapor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Alcohol-oxygen vapor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Corticosteroid and/or corticosteroid derivative therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Diagnostic intravenous injection of edrophonium | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of total parenteral nutrition | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Measles morbillivirus and Rubella virus antigens | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 3 | 
| Administration of consolidation antineoplastic agent | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Augmentation of labor using oxytocin | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of ergometrine and oxytocin | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of ergometrine and oxytocin | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Short-term drug therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Dengue virus antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of hyperthermic antineoplastic agent into peritoneal cavity | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of hyperthermic antineoplastic agent into thoracic cavity | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic platelet aggregation inhibitor | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic platelet aggregation inhibitor | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 3 | 
| Platelet aggregation inhibitor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Platelet aggregation inhibitor therapy | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Administration of substance via enteral route | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of insulin using insulin pump | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of substance via gastroenteral route | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Antenatal therapeutic administration of corticosteroid | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Ocrelizumab therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic anti-infective agent for Pneumocystosis jirovecii pneumonia | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of booster dose of vaccine product containing only Hepatitis A virus antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Administration of vaccine product containing only Measles morbillivirus and Rubella virus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of booster dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of antiarrhythmic drug via oral route | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of booster dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of multimodal anesthesia | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic drug or medicament for graft-versus-host disease | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of third dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 3 | 
| Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 3 | 
| Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 4 | 
| Proton pump inhibitor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Vasopressor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Immune checkpoint inhibitor therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Artesunate therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Heated and humidified high flow oxygen therapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of human anti-D immunoglobulin | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of remdesivir | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of third dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Preschool administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Preschool administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of essential fatty acid | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen in oral dose form | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of pediatric vaccine product containing only Hepatitis A virus antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of third dose of pediatric vaccine product containing only Hepatitis A virus antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of booster dose of pediatric vaccine product containing only Hepatitis A virus antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of pneumococcal 7-valent conjugate vaccine | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup C antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup B antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of RhD immune globulin | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Intravenous infusion of Cytomegalovirus immune globulin | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Administration of human anti-D immunoglobulin | Method | False | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of parenteral nutrition | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of sedative via nasal route | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of multiple antineoplastic agents | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic antiviral | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Administration of prophylactic antifungal | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Antineoplastic chemoimmunotherapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Antineoplastic chemoimmunotherapy | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 2 | 
| Increased polyunsaturated fat diet | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 | 
| Decreased potassium diet | Method | True | Administration - action | Inferred relationship | Existential restriction modifier | 1 |